8.80Open8.80Pre Close0 Volume0 Open Interest18.00Strike Price0.00Turnover212.81%IV-32.56%PremiumOct 18, 2024Expiry Date11.06Intrinsic Value100Multiplier21DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9503Delta0.0347Gamma0.63Leverage Ratio-0.0071Theta-0.0049Rho-0.59Eff Leverage0.0017Vega
SIGA Technologies Stock Discussion
https://www.msn.com/en-us/health/other/la-county-mpox-cases-are-rising-what-s-driving-the-increase/ar-AA1rbgw4?ocid=msedgdhp&pc=U531&cvid=3d9cefae83aa481fa5b56d8a24ecd771&ei=18
It's in Spain now.
Partnerships between pharmaceutical companies and government agencies are crucial for advancing public health initiatives. A prime example of such collaboration is the recent contract awarded to SIGA Technologies, Inc. by the U.S. Department of Defense (DOD) for the procurement of TPOXX®, a critical antiviral medicati...
$Virax Biolabs (VRAX.US)$ $GeoVax Labs (GOVX.US)$ $Emergent BioSolutions (EBS.US)$ $Applied DNA Sciences (APDN.US)$ $SIGA Technologies (SIGA.US)$ $E-Home Household Service (EJH.US)$
📊⚡️📊
SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®
SIGA Technologies (NASDAQ: SIGA) has secured a new $9 million contract with the U.S. Department of Defense for the procurement of TPOXX®, an antiviral medication. This marks the third DOD contract in three years for SIGA. The order primarily consists of oral TPOXX®, with a small amount of intravenous formulation included.
SIGA is also collaborating with ...
Investors are buying up shares of vaccine producers, antiviral drug makers, and protective equipment companies, hoping to profit as they did during the coronavirus pandemic.
Bavarian Nordic, the only producer approved of the pox vaccine, saw its shares jump 16.5% on the day in...
No comment yet